Hubbry Logo
Restriction siteRestriction siteMain
Open search
Restriction site
Community hub
Restriction site
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Restriction site
Restriction site
Restriction site
View on Wikipedia
from Wikipedia

In molecular biology, restriction sites, or restriction recognition sites, are regions of a DNA molecule containing specific (4-8 base pairs in length[1]) sequences of nucleotides; these are recognized by restriction enzymes, which cleave the DNA at or near the site. These are generally palindromic sequences[2] (because restriction enzymes usually bind as homodimers), and a particular restriction enzyme may cut the sequence between two nucleotides within its recognition site, or somewhere nearby.

Function

[edit]

For example, the common restriction enzyme EcoRI recognizes the palindromic sequence GAATTC and cuts between the G and the A on both the top and bottom strands. This leaves an overhang (an end-portion of a DNA strand with no attached complement) known as a sticky end[2] on each end of AATT (AATTC, i.e. TTAAC). The overhang can then be used to ligate in (see DNA ligase) a piece of DNA with a complementary overhang (another EcoRI-cut piece, for example).

Some restriction enzymes cut DNA at a restriction site in a manner which leaves no overhang, called a blunt end.[2] Blunt ends are much less likely to be ligated by a DNA ligase because the blunt end doesn't have the overhanging base pair that the enzyme can recognize and match with a complementary pair.[3] Sticky ends of DNA however are more likely to successfully bind with the help of a DNA ligase because of the exposed and unpaired nucleotides. For example, a sticky end trailing with AATTG is more likely to bind with a ligase than a blunt end where both the 5' and 3' DNA strands are paired. In the case of the example the AATTG would have a complementary pair of TTAAC which would reduce the functionality of the DNA ligase enzyme.[4]

Applications

[edit]

Restriction sites can be used for multiple applications in molecular biology such as identifying restriction fragment length polymorphisms (RFLPs). Restriction sites are also important consideration to be aware of when designing plasmids.

Databases

[edit]

Several databases exist for restriction sites and enzymes, of which the largest noncommercial database is REBASE.[5][6] Recently, it has been shown that statistically significant nullomers (i.e. short absent motifs which are highly expected to exist) in virus genomes are restriction sites indicating that viruses have probably got rid of these motifs to facilitate invasion of bacterial hosts.[7] Nullomers Database contains a comprehensive catalogue of minimal absent motifs many of which might potentially be not-yet-known restriction motifs.

See also

[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Restriction site

View on Grokipedia
from Grokipedia
A restriction site, also known as a recognition site, is a short, specific nucleotide sequence in double-stranded DNA that is recognized and cleaved by a restriction enzyme, or restriction endonuclease, a protein derived from bacteria. These sites typically range from 4 to 8 base pairs in length and are often palindromic, meaning the sequence on one strand reads identical to the sequence on the complementary strand when both are oriented from 5' to 3'. For example, the EcoRI restriction enzyme targets the palindromic sequence 5'-GAATTC-3', cleaving the DNA to produce sticky ends with overhanging single strands. In their natural biological context, restriction sites function as part of bacterial restriction-modification (R-M) systems, which serve as a primitive immune defense against invading foreign DNA, such as from bacteriophages. Within these systems, restriction enzymes bind to unmethylated restriction sites on foreign DNA and hydrolyze the phosphodiester bonds, fragmenting it into non-viable pieces, while the bacterium's own DNA is protected by site-specific methylation performed by companion modification enzymes. This selective cleavage prevents viral replication and horizontal gene transfer, contributing to bacterial genome stability and diversity across prokaryotic species. The discovery of restriction sites and enzymes occurred in the mid-20th century, beginning with genetic observations of host-controlled restriction in bacteriophage infections by Salvador Luria, Mary Human, and others in the early 1950s. Werner Arber and colleagues elucidated the enzymatic basis in the 1960s, with Hamilton Smith isolating the first Type II restriction enzyme (HindII) in 1970, which cuts at a defined four-base-pair site. These breakthroughs, along with Daniel Nathans' applications in DNA mapping, earned Arber, Smith, and Nathans the 1978 Nobel Prize in Physiology or Medicine. Restriction enzymes are classified into Types I through IV based on composition, cofactor needs, and cleavage mechanisms, but Type II enzymes—homo- or heterodimers that cleave precisely within or adjacent to the palindromic site—are the most prevalent in nature and biotechnology, with over 4,700 Type II enzymes characterized as of 2022. Restriction sites have transformed into a precise , enabling techniques since the 1970s by allowing targeted fragmentation and ligation of genetic material. Key applications include gene cloning, where compatible sticky or blunt ends from matching sites facilitate DNA insertion into vectors; physical mapping; and early methods. In forensics and diagnostics, variations in restriction sites underpin (RFLP) analysis for DNA fingerprinting and mutation detection. Today, these tools remain foundational to , , and therapeutic development, despite the rise of sequence-independent alternatives like .

Fundamentals

Definition

A restriction site, also known as a recognition site, is a specific, short DNA sequence—typically 4 to 8 base pairs in length—that is recognized and cleaved by a restriction endonuclease, commonly referred to as a restriction enzyme. These enzymes act as molecular scissors, enabling precise cuts in double-stranded DNA molecules at these predetermined locations. The phenomenon of restriction was first observed in the 1950s through studies on bacteriophage infections of Escherichia coli, with key insights into host-controlled modification emerging in the 1960s from work on bacteriophage lambda. This laid the groundwork for the 1970s isolation and purification of the first Type II restriction enzymes, such as HindII in 1970 and EcoRI in 1971, and the mapping of their corresponding recognition sequences. These discoveries elucidated the restriction-modification systems, where enzymes cleave unmethylated foreign DNA at specific sites while protecting the host genome through methylation. In the context of genetic engineering, the double-helical structure of DNA necessitates such precise cutting tools to manipulate genetic material without unintended damage, facilitating techniques like recombinant DNA construction. For instance, the EcoRI restriction site is defined by the palindromic sequence 5'-GAATTC-3', which the enzyme recognizes across both strands of the DNA double helix.

Recognition Sequence

A recognition sequence, also known as the recognition site or target sequence, is a short, specific stretch of double-stranded DNA that restriction enzymes identify and bind to initiate cleavage. These sequences typically range from 4 to 8 nucleotides in length, with 6-base-pair motifs being the most common among type II restriction endonucleases, which are widely used in molecular biology. The composition of these sequences is highly precise, often featuring dyad symmetry—palindromic arrangements where the sequence reads the same on both strands in the 5' to 3' direction—facilitating symmetric binding by the dimeric enzyme structure. For instance, sequences like 5'-GAATTC-3' lead to the generation of sticky (cohesive) ends with 5' overhangs upon cleavage, whereas 5'-CCCGGG-3' produces blunt ends with flush termini. This structural variation in the recognition sequence influences the type of DNA fragments generated, impacting downstream applications such as ligation efficiency in cloning. Restriction enzymes demonstrate stringent sequence specificity, requiring an exact match to the recognition sequence for effective binding and cleavage; single nucleotide mismatches within the core motif generally abolish or severely reduce enzymatic activity, ensuring targeted action on foreign DNA. While the primary specificity is dictated by the recognition sequence itself, certain enzymes exhibit sensitivity to immediately adjacent flanking sequences, which can modulate cleavage rates by up to several fold depending on their nucleotide composition. This flanking influence arises from subtle interactions that affect the enzyme's conformational changes during catalysis, though it remains secondary to the core sequence fidelity. In the context of bacterial restriction-modification (RM) systems, recognition sequences serve as conserved elements for host defense, enabling the discrimination and degradation of invading foreign DNA such as bacteriophages while sparing the methylated host genome. These systems, comprising a restriction endonuclease and a methyltransferase, are phylogenetically widespread across prokaryotic , with the recognition motifs maintained to provide robust protection against threats. The conservation of RM architectures underscores the evolutionary pressure to preserve these sequences as integral components of innate immunity in microbes. To accommodate natural sequence variations or degenerate sites recognized by certain enzymes, recognition sequences are conventionally notated using the International Union of Pure and Applied Chemistry (IUPAC) ambiguity codes. These include R for purines (A or G), Y for pyrimidines (C or T), S for strong hydrogen-bonding pairs (G or C), W for weak pairs (A or T), M for amino bases (A or C), K for keto bases (G or T), B for all bases except A (C, G, or T), D for all except C (A, G, or T), H for all except G (A, C, or T), and V for all except T (A, C, or G), with N denoting any base (A, C, G, or T). This standardized notation allows precise description of partially degenerate motifs without listing every possible variant, aiding in database annotation and enzyme classification.

Function and Mechanism

Enzyme Recognition

Restriction enzymes, particularly type II endonucleases, identify their target sequences through a highly specific binding process that involves the formation of homodimers or, in some cases, homotetramers, which symmetrically interact with the palindromic DNA recognition sites. These enzymes initially bind non-specifically to DNA via electrostatic interactions with the phosphodiester backbone, allowing them to scan the genome efficiently. Upon encountering a potential recognition site, the enzyme undergoes a conformational change, wrapping around the DNA double helix and making direct contacts with both the major and minor grooves. For instance, in enzymes like EcoRI and BamHI, structural elements such as recognition arms insert into the minor groove, while the core domains primarily engage the major groove to probe the base sequence. This binding is stabilized by approximately 15-20 hydrogen bonds between amino acid side chains and the bases of the recognition sequence, complemented by van der Waals interactions that provide additional specificity by sensing the shape and hydrophobicity of the base edges. The specificity of recognition is determined by precise contact points for each base in the 4-8 bp sequence, often involving direct readout via bonds to exocyclic groups on the bases and indirect readout through deformation of the DNA backbone. Enzymes like EcoRV exemplify this by forming specific bonds with outer base pairs (e.g., G-A contacts via residues like Asn185) and using van der Waals forces with methyl groups for inner pairs, ensuring discrimination against non-cognate sites. Magnesium ions (Mg²⁺) play a crucial role in some enzymes by coordinating with catalytic motifs (e.g., PD...D/EXK) during the transition to the cleavage-competent state, although their primary function is in ; in recognition, they may stabilize the enzyme-DNA complex in certain type II systems. This multi-step process—initial non-specific binding, partial recognition, and tight specific complex formation—achieves high fidelity, with enzymes like EcoRV bending DNA by up to 50° upon cognate site verification to lock in the interaction. In the context of restriction-modification (RM) systems, the endonuclease is paired with a methyltransferase that modifies the host at the same recognition site, typically by adding methyl groups to (N6-methyladenine) or (5-) residues, thereby preventing self-cleavage. This modification disrupts key hydrogen bonds or steric contacts in the endonuclease , as seen in EcoRV where adenine methylation abolishes binding affinity. The kinetic aspect of recognition involves , where the enzyme forms a non-specific complex and performs one-dimensional sliding along the , combined with three-dimensional hopping, to locate target sites rapidly without off-target cleavage; studies on BssHII demonstrate linear scanning that halts at the first site encountered, ensuring precise and efficient protection.

Cleavage Specificity

Restriction enzymes cleave DNA at precise positions within or adjacent to their recognition sequences, generating either cohesive (sticky) ends with single-stranded overhangs or blunt ends without overhangs. In the most common type II restriction endonucleases, cleavage occurs at fixed positions relative to the recognition site, typically producing 5' or 3' overhangs of 1-4 nucleotides in length or blunt ends. For instance, EcoRI recognizes the sequence 5'-GAATTC-3' and cleaves between G and A on both strands, resulting in 5' overhangs of four bases (AATT):

5'-G AATTC-3' 3'-CTTAA G-5'

5'-G AATTC-3' 3'-CTTAA G-5'

This produces sticky ends that facilitate ligation in . In contrast, SmaI recognizes 5'-CCCGGG-3' and cleaves between the central C and G, yielding blunt ends:

5'-CCC GGG-3' 3'-GGG CCC-5'

5'-CCC GGG-3' 3'-GGG CCC-5'

Such blunt ends allow ligation to any compatible terminus but may reduce efficiency compared to sticky ends. Type II enzymes, which account for the majority used in biotechnology, perform this cleavage in a magnesium-dependent manner without requiring ATP, distinguishing them from type I and type III enzymes. Type I endonucleases cleave at distant, variable positions (often thousands of base pairs away) from the recognition site, while type III enzymes cut at fixed but offset positions (20-30 base pairs away), both relying on ATP for translocation along DNA. Despite these differences, the recognition sequences for all types are defined similarly, but type II's precise, site-localized cuts make them preferable for routine applications. Several environmental and biochemical factors influence the efficiency or occurrence of cleavage by restriction s. Salt concentration, particularly monovalent cations like Na⁺ or K⁺, modulates activity; high levels (e.g., >100 mM) can inhibit binding or by altering electrostatic interactions, while optimal concentrations (typically 50-100 mM) are provided in commercial buffers. affects reaction kinetics and stability, with most enzymes active at 37°C but some requiring lower (e.g., 25°C) or higher temperatures to achieve maximal efficiency without denaturation. status at or near the recognition site often prevents cleavage in sensitive enzymes; for example, Dcm blocks enzymes like EcoRII, while CpG blocks SmaI, protecting host DNA but necessitating unmethylated substrates or -insensitive variants for work.

Types and Variations

Palindromic Sites

Palindromic restriction sites are specific DNA sequences that exhibit symmetry, reading the same in the 5' to 3' direction on both complementary strands. This inverted repeat structure allows the sequence to be identical when one strand is read forward and the complementary strand is read in reverse. A classic example is the recognition site for the EcoRI enzyme, 5'-GAATTC-3', where the top strand (GAATTC) matches the bottom strand when reversed (also GAATTC). These sites predominate among Type II restriction endonucleases, with over 90% of commercially utilized enzymes recognizing palindromic sequences of 4 to 8 base pairs. This prevalence stems from the structural compatibility with the enzymes' homodimeric , where each subunit binds one half of the symmetric site. Notable examples include , which targets 5'-GGATCC-3', and , recognizing 5'-AAGCTT-3'. The palindromic nature facilitates precise, symmetric cleavage, often producing sticky ends that enhance ligation efficiency in molecular applications. The advantages of palindromic sites lie in their promotion of cooperative binding by the enzyme's subunits, enabling simultaneous interaction with both DNA strands through hydrogen bonds and van der Waals contacts for high specificity. This symmetric engagement ensures efficient cleavage within or near the site, minimizing off-target effects. Evolutionarily, these sites are integral to bacterial restriction-modification systems, serving as a frontline defense against foreign DNA like phages by enabling rapid detection and degradation, with genomic avoidance patterns reflecting an ongoing between hosts and invaders.

Non-Palindromic Sites

Non-palindromic restriction sites consist of asymmetric DNA sequences that lack the rotational symmetry characteristic of palindromic sites, requiring enzymes to bind in a directional manner to recognize and cleave the DNA. These sites are typically 4 to 7 base pairs long and are predominantly associated with Type IIS restriction endonucleases, which separate the recognition and cleavage functions into distinct domains. Unlike palindromic sites, cleavage occurs outside the recognition sequence, often producing single-stranded overhangs that do not include the recognition motif itself, enabling precise and orientation-specific ligation. For instance, the enzyme MboII recognizes the 5'-GAAGA-3' sequence and cleaves 8 nucleotides downstream on the forward strand and 7 on the reverse strand, resulting in a 1-nucleotide stagger. The enzymes that target non-palindromic sites exhibit specialized adaptations to accommodate the lack of symmetry, often operating as monomers with modular structures that include a DNA-binding domain for sequence-specific recognition and a separate catalytic domain for phosphodiester bond hydrolysis. A prominent example is FokI, which recognizes the asymmetric 5'-GGATG(9/13)-3' sequence and introduces cuts 9 nucleotides downstream on the forward strand and 13 on the reverse, generating 4-nucleotide overhangs. FokI functions as a monomer but requires dimerization—typically by binding to two nearby sites—to achieve efficient double-strand breakage, highlighting the need for cooperative interactions in these systems. Some Type IIS enzymes may involve additional subunits or dimeric assemblies to ensure coordinated cleavage across both strands. Non-palindromic sites are less common among restriction endonucleases, comprising approximately 5-10% of known types, as Type IIP enzymes that target palindromic sequences dominate with over 90% prevalence in applications. Their rarity stems from the evolutionary advantages of symmetric sites in bacterial defense systems, but non-palindromic sites offer unique utilities, particularly in directional strategies such as assembly, where the offset cleavage allows scarless joining of fragments in a defined orientation without residual enzyme sites. However, these enzymes often demand multiple recognition sites (at least two) for optimal activity, as seen with MboII and , which can limit their efficiency in substrates with sparse or isolated sites and necessitate careful experimental design.

Applications

Molecular Cloning

Molecular cloning relies on restriction sites to facilitate the assembly of molecules by precisely cutting and joining DNA fragments. The process begins with the of both a vector, such as a , and an insert DNA fragment using the same , which recognizes specific sequences and generates compatible ends. These ends are then ligated using to form a stable that can be introduced into a host cell for propagation. This method was foundational in enabling the construction of biologically functional bacterial plasmids , as demonstrated in early experiments. Compatible ends produced by restriction enzymes, particularly sticky ends with overhanging single-stranded sequences, promote efficient annealing between the vector and insert, increasing ligation success rates compared to blunt ends. is crucial for optimizing efficiency; researchers often choose isoschizomers—enzymes from different organisms that recognize and cleave the same sequence—or neoschizomers, which recognize the same sequence but cleave at different positions within it, to provide flexibility when a preferred enzyme is unavailable or incompatible with downstream applications. For instance, if sensitivity affects one enzyme's activity in a given DNA preparation, an alternative isoschizomer can be substituted without altering the cut site. A common technique involves using plasmids with a (MCS), a cluster of unique restriction sites positioned within a such as lacZα, to enable insertional inactivation. When an insert disrupts the lacZα sequence, the resulting recombinant plasmids fail to produce functional , allowing identification via blue-white screening: non-recombinant colonies appear blue on media containing and IPTG, while recombinants are white. This screening method simplifies the selection of successful clones without extensive sequencing. The landmark 1973 experiment by Stanley Cohen and utilized restriction enzymes to join DNA fragments from different plasmids, creating the first molecules and establishing as a cornerstone of .

Genome Mapping

Restriction mapping involves determining the positions of restriction sites within molecule by analyzing the sizes of fragments produced through partial or complete enzymatic digestion, typically resolved via . Partial digests, where the reaction is limited to cleave only a subset of sites, generate overlapping fragments that can be sized and ordered to infer the , often using techniques like or for separation and visualization. In applications prior to widespread sequencing, restriction mapping played a key role in constructing physical maps of large DNA regions by employing (PFGE) to resolve megabase-sized fragments from rare-cutting enzymes, which recognize infrequent sequences and produce fewer, larger pieces suitable for chromosomal-scale analysis. This approach facilitated the assembly of contigs—contiguous sequences of overlapping clones—essential for anchoring genetic markers and guiding early genome projects. For instance, in the , rare-cutting enzymes like NotI and SfiI were used in PFGE-based mapping to create overlapping contigs across human chromosomes, enabling the initial framework for the assembly. Contemporary applications integrate restriction enzymes with (PCR) and next-generation sequencing (NGS) to enhance variant detection, such as in restriction endonuclease-mediated selective PCR (REMS-PCR), which amplifies mutant alleles by exploiting site-specific cleavage differences for sensitive identification of low-frequency variants like KRAS mutations in cancer samples. Additionally, methylation-sensitive restriction enzymes, which cleave only at unmethylated or methylated sites depending on their specificity, enable epigenomic profiling to map patterns, revealing regulatory elements in without full sequencing. These methods leverage the cleavage specificity of enzymes—whether producing blunt or sticky ends—to improve mapping resolution in targeted analyses.

Forensics and Diagnostics

Restriction sites are central to restriction fragment length polymorphism (RFLP) analysis, a technique that detects variations in DNA sequence through differences in fragment lengths produced by restriction enzyme digestion. These polymorphisms arise from mutations that create, eliminate, or alter restriction sites, leading to variable fragment sizes separable by gel electrophoresis and detectable via Southern blotting with labeled probes. RFLP was pivotal in early DNA fingerprinting for forensic identification, paternity testing, and linkage analysis in genetic studies, though largely supplanted by PCR-based methods like STR profiling due to higher sensitivity and smaller sample requirements. In diagnostics, RFLP identifies specific mutations, such as those in sickle cell anemia or cystic fibrosis, by comparing fragment patterns to known standards, aiding in disease diagnosis and carrier screening.

Resources

Databases

REBASE serves as the primary comprehensive database for restriction enzymes and their recognition sites, maintained by (NEB). It curates detailed information on restriction-modification systems, including recognition sequences, cleavage patterns, and associated proteins such as methyltransferases. As of September 2022, REBASE encompassed data on over 4,700 Type II restriction enzymes, enabling users to query specifics like palindromic versus non-palindromic sites. Integrated with REBASE, NEBcutter provides a tool-linked database functionality for predicting restriction sites within user-submitted DNA sequences, generating reports on potential cleavage positions based on the catalog. This resource draws directly from REBASE's data to simulate digests and identify compatible sites for experimental design. For coli-specific restriction data, EcoCyc offers curated entries on restriction-modification systems, such as the EcoKI Type I system, including details on modification enzymes and their roles in patterns. REBASE and similar repositories also incorporate updates on sensitivity, noting how certain enzymes are blocked or enhanced by base modifications at recognition sites. These databases are freely accessible online, with REBASE providing downloadable files and search interfaces for broad use, and all resources undergo regular curation to reflect new enzyme discoveries and genomic insights.

Analysis Tools

Analysis tools for restriction sites enable prediction and visualization of recognition and cleavage patterns in DNA sequences, facilitating workflows without physical experimentation. These software packages typically accept user-provided sequences as input and generate outputs such as site locations, fragment size maps, and simulated digests, often drawing on comprehensive enzyme databases for accuracy. Key prediction software includes NEBcutter, developed by , which simulates restriction digests by identifying all applicable enzyme sites in linear or circular DNA up to 300,000 bases long, producing detailed reports on cut positions, fragment lengths, and virtual gel electrophoresis visualizations. Similarly, RestrictionMapper provides an online platform for mapping sites and performing virtual digests, allowing users to filter enzymes by criteria like maximum cuts or minimum recognition sequence length, and outputs graphical maps of fragment distributions. Both tools support rapid analysis for strategy design, with NEBcutter emphasizing compatibility with common vector sequences. For visualization, integrated platforms like Geneious and SnapGene combine restriction site analysis with broader sequence editing capabilities, displaying sites as annotated features on circular or linear maps alongside primers, ORFs, and other elements. Geneious enables selection of sets based on overhangs or types, simulates multi- digests, and highlights potential ligation products in a graphical interface. SnapGene similarly offers customizable views of restriction sites, with tools to scan large sequences, annotate cuts, and preview digest results in gel simulations, streamlining design and verification. Advanced features in these tools account for biological nuances, such as sensitivity—NEBcutter flags enzymes affected by or Dcm methylation using data from REBASE—and isoschizomer selection, where users can choose alternatives with differing cleavage patterns via finders in Geneious or SnapGene. for entire genomes is supported in scalable environments, like Geneious' for high-throughput site scanning across contigs. Tools often reference databases like REBASE for catalogs, ensuring predictions reflect verified specificities. Limitations of these analysis tools include dependency on the completeness of underlying catalogs, which may overlook rare or newly discovered restriction endonucleases until database updates occur, potentially leading to incomplete maps for non-standard sequences. Additionally, while and isoschizomer handling improves realism, predictions assume standard conditions and may require manual verification for context-specific factors like sequence context or enzyme star activity.

References

  1. https://www.genome.gov/genetics-glossary/Restriction-Enzyme
  2. https://eaglepubs.erau.edu/cellandmoleclab/chapter/restriction-enzymes/
  3. https://www.life.illinois.edu/molbio/background/background.html
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC5333194/
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC1087929/
  6. https://academic.oup.com/nar/article/51/D1/D629/6786197
  7. https://www.genome.gov/genetics-glossary/Restriction-Fragment-Length-Polymorphism-RFLP
  8. https://www.sciencedirect.com/topics/immunology-and-microbiology/restriction-site
  9. https://www.thermofisher.com/us/en/home/life-science/cloning/cloning-learning-center/invitrogen-school-of-molecular-biology/molecular-cloning/restriction-enzymes/restriction-enzyme-basics.html
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC3874209/
  11. https://www.nature.com/scitable/spotlight/restriction-enzymes-18458113/
  12. https://www.khanacademy.org/science/biology/biotech-dna-technology/dna-cloning-tutorial/a/restriction-enzymes-dna-ligase
  13. https://pubmed.ncbi.nlm.nih.gov/11557805/
  14. https://pubmed.ncbi.nlm.nih.gov/7624794/
  15. https://pubmed.ncbi.nlm.nih.gov/20600128/
  16. https://pubmed.ncbi.nlm.nih.gov/9210460/
  17. https://pubmed.ncbi.nlm.nih.gov/8567625/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC55916/
  19. https://www.neb.com/en-us/tools-and-resources/selection-charts/dam-dcm-and-cpg-methylation
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC4081073/
  21. https://www.neb.com/en-us/tools-and-resources/usage-guidelines/optimizing-restriction-endonuclease-reactions
  22. https://www.neb.com/en-us/products/r0101-ecori
  23. https://www.neb.com/en-us/tools-and-resources/feature-articles/everything-you-ever-wanted-to-know-about-type-ii-restriction-enzymes
  24. https://www.neb.com/en-us/products/r0136-bamhi
  25. https://www.neb.com/en-us/products/r0104-hindiii
  26. https://pubmed.ncbi.nlm.nih.gov/11381024/
  27. https://www.jbc.org/article/S0021-9258%2820%2987875-2/fulltext
  28. https://www.thermofisher.com/order/catalog/product/ER0821
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC1410913/
  30. https://www.neb.com/en-us/products/r0109-foki
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC10201449/
  32. https://www.thermofisher.com/us/en/home/brands/thermo-scientific/molecular-biology/molecular-biology-learning-center/molecular-biology-resource-library/spotlight-articles/scarless-cloning-larger-dna-sequences-type-iis.html
  33. https://www.neb.com/en/products/r0148-mboii
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC427208/
  35. https://www.nature.com/articles/miledna02
  36. https://www.neb.com/en-us/tools-and-resources/feature-articles/foundations-of-molecular-cloning-past-present-and-future
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC6302727/
  38. https://pubmed.ncbi.nlm.nih.gov/787937/
  39. https://pubmed.ncbi.nlm.nih.gov/321023/
  40. https://pubmed.ncbi.nlm.nih.gov/1840881/
  41. https://www.genome.gov/sites/default/files/media/files/2024-08/Green_MMBID_2001.pdf
  42. https://www.pnas.org/doi/pdf/10.1073/pnas.88.23.10609
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC9865676/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC5749185/
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC3624772/
  46. https://www.ncbi.nlm.nih.gov/books/NBK21314/
  47. https://www.neb.com/tools-and-resources/interactive-tools/nebcutter
  48. https://biocyc.org/complex?orgid=ECOLI&id=CPLX0-3958
  49. https://rebase.neb.com/rebase/rebase.html
  50. https://www.restrictionmapper.org/
  51. https://www.geneious.com/features/molecular-cloning
  52. https://www.snapgene.com/features
  53. https://www.geneious.com/features/workflows
Add your contribution
Related Hubs
User Avatar
No comments yet.